Tumor Initiating Cells and Chemoresistance: Which Is the Best Strategy to Target Colon Cancer Stem Cells?

There is an emerging body of evidence that chemoresistance and minimal residual disease result from selective resistance of a cell subpopulation from the original tumor that is molecularly and phenotypically distinct. These cells are called “cancer stem cells” (CSCs). In this review, we analyze the...

Descripción completa

Detalles Bibliográficos
Autores principales: Paldino, Emanuela, Tesori, Valentina, Casalbore, Patrizia, Gasbarrini, Antonio, Puglisi, Maria Ausiliatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914574/
https://www.ncbi.nlm.nih.gov/pubmed/24527460
http://dx.doi.org/10.1155/2014/859871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914574/
https://www.ncbi.nlm.nih.gov/pubmed/24527460
http://dx.doi.org/10.1155/2014/859871

Ejemplares similares